Related Experiment Videos
Long distance heart transplantation: a tale of two cities
Pankaj Jain1, Roslyn A Prichard1,2, Mark B Connellan1,3
1Heart Transplant Unit, St Vincent's Hospital, Sydney, New South Wales, Australia.
Insights
Normothermic ex vivo perfusion (NEVP) for donor heart transport, despite higher initial costs, reduced overall inpatient expenses compared to traditional ice chest transport. This method offers a potential economic advantage in heart transplantation.
Area of Science:
- Cardiovascular Surgery
- Organ Transplantation
- Medical Technology
Background:
- Donor heart preservation is critical for successful transplantation.
- Prolonged organ transport poses significant challenges.
- Evaluating novel preservation methods is essential for improving outcomes.
Observation:
- Two heart transplant cases are presented with prolonged donor heart transportation times.
- One donor heart was preserved using a standard ice chest method.
- The second donor heart utilized a normothermic ex vivo perfusion (NEVP) system.
Findings:
- NEVP transport, while incurring higher retrieval costs, led to reduced subsequent inpatient costs.
- This suggests a potential cost-benefit advantage for NEVP in specific scenarios.
- Comparison highlights differences in resource utilization between preservation methods.
Implications:
- NEVP may offer a cost-effective solution for managing long-distance organ transport.
- Further research into NEVP's economic impact on transplantation is warranted.
- Optimizing organ preservation strategies can improve transplant efficiency and patient care.
Abstract:
In this 'paired' case report, we describe two heart transplants performed 3 days apart at our centre. Both cases involved very prolonged transportation time of the donor heart. In one case, the donor heart was transported in an ice chest, while in the other case the organ was transported using a normothermic ex vivo perfusion (NEVP) system. The additional retrieval costs incurred by the use NEVP were more than offset by the reduction in subsequent inpatient costs.